<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="Tab4">
 <label>Table 4.4</label>
 <caption>
  <p>Features of currently licensed vaccines</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th align="left">Vaccine</th>
    <th align="left">Parent strain and genotype</th>
    <th align="left">Formulation</th>
    <th align="left">Dose</th>
    <th align="left">Side effects</th>
    <th align="left">Protective efficacy</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="left">Rota Teq</td>
    <td align="left">Bovine rotavirus strain WC3, P7[5]G6</td>
    <td align="left">5 reassortants; 4 reassortants with the VP7 specificity for serotype 1, 2, 3, or 4, and 1 reassortant with the VP4 of P1A[8] specificity from the human rotavirus parent strain with the remainder of the genes from the WC3 bovine rotavirus parent</td>
    <td align="left">3 oral doses at 2, 4, and 6 months of age</td>
    <td align="left">Intussusceptions not seen. Diarrhea and vomiting may occur</td>
    <td align="left">
     <p>84.7 % against</p>
     <p>severe gastroenteritis</p>
     <p>and hospitalization</p>
    </td>
   </tr>
   <tr>
    <td align="left">Rotarix</td>
    <td align="left">Human rotavirus strain 89-12, G1 P1A[8]</td>
    <td align="left">No reassortants; attenuation by passage of human rotavirus 89-12 strain in tissue culture</td>
    <td align="left">2 oral doses at 2 and 4 months of age</td>
    <td align="left">Intussusceptions not seen. Diarrhea and vomiting may occur</td>
    <td align="left">89 % against all rotavirus disease</td>
   </tr>
  </tbody>
 </table>
</table-wrap>
